C12003-2 14-3-3 protein eta antibody

See related secondary antibodies

Search for all "14-3-3 protein eta"

0.1 mg / €290.00
Please visit the appropriate website of Acris Antibodies or contact your local Distributor to buy this product.

Quick Overview

Rabbit anti Human, Mouse, Rat 14-3-3 protein eta

C12003-2

More Views

  • C12003-2

Product Description for 14-3-3 protein eta

Rabbit anti Human, Mouse, Rat 14-3-3 protein eta.
Presentation: Aff - Purified
Product is tested for Enzyme Immunoassay, Immunocytochemistry/Immunofluorescence, Western blot / Immunoblot.

Properties for 14-3-3 protein eta

Product Category Antibodies
Quantity 0.1 mg
Synonyms FocusOn116, Protein AS1, YWHA1, YWHAH
Presentation Aff - Purified
Reactivity Hu, Ms, Rt
Applications E, ICC/IF, WB
Clonality Polyclonal
Host Rabbit
Shipping to Europe only
PDF datasheet View Datasheet
Manufacturer Assay Biotech

Datasheet Extract

Immunogen
Swiss Prot Num:
Q04917
Genename:
7533
Antibody type Ab
Format
State:
Aff - Purified
Gene ID 7533
Targets

Accessory Products

Proteins and/or Positive Controls

Proteins for 14-3-3 protein eta (4 products)

Catalog No. Species Pres. Purity   Source  
AR09102PU-L

14-3-3 protein eta (1-246, His-tag)

14-3-3 eta, 1-246 aa, His-tagged: 15% SDS-PAGE (4 µg) Human Purified ≥ 95 E. coli
0.5 mg / €750.00
  Acris Antibodies GmbH
AR09102PU-N

14-3-3 protein eta (1-246, His-tag)

14-3-3 eta, 1-246 aa, His-tagged: 15% SDS-PAGE (4 µg) Human Purified ≥ 95 E. coli
0.1 mg / €300.00
  Acris Antibodies GmbH
H00007533-Q01-10

14-3-3 protein eta

14-3-3 protein eta Human in vitro transl.
10 µg / €350.00
  Abnova Taiwan Corp.
H00007533-Q01-25

14-3-3 protein eta

14-3-3 protein eta Human in vitro transl.
25 µg / €500.00
  Abnova Taiwan Corp.

Positive controls for 14-3-3 protein eta (1 products)

Catalog No. Species Pres. Purity   Source  
NBL1-17950

14-3-3 eta Lysate

Western Blot: 14-3-3 eta Lysate [NBL1-17950] - Western Blot experiments. 
Left-Control; Right -Over-expression Lysate for YWHAH
0.1 mg / €370.00
  Novus Biologicals Inc.